Phenylbutazonecalcium(CAS: 70145-60-7)

Phenylbutazonecalcium (CAS: 70145-60-7) is subject to various regulatory guidelines. It falls under the Globally Harmonized System of Classification and Labeling of Chemicals (GHS) for its health and environmental hazards. In the European Union, it must comply with REACH regulations for chemical safety. Additionally, the Food and Drug Administration (FDA) and Environmental Protection Agency (EPA) have specific requirements for its use and disposal to ensure public health and environmental safety.

Phenylbutazonecalcium (CAS: 70145-60-7) can be synthesized using alternative reagents such as other calcium salts or derivatives of phenylbutazone. Common alternatives include phenylbutazone sodium and other non-steroidal anti-inflammatory drugs (NSAIDs). These alternatives offer similar therapeutic effects but may vary in potency, bioavailability, and side-effect profiles.

Phenylbutazonecalcium (CAS: 70145-60-7) is not widely used in current medical practices due to its side effects. However, there is ongoing research into its potential applications in veterinary medicine and its use as a reference compound for studying drug metabolism. Market trends indicate a shift towards safer and more effective alternatives, but phenylbutazonecalcium remains important for historical and academic study.

Waste containing Phenylbutazonecalcium (CAS: 70145-60-7) should be collected in appropriate containers and disposed of through professional hazardous waste disposal services. Incineration is a common method for waste disposal, but it should be conducted in accordance with local regulations to minimize environmental impact. Proper safety precautions, including personal protective equipment and containment measures, must be followed to prevent contamination and exposure to hazardous materials.